LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	GSK1059615	0.04	uM	LJP5	72	hr	1657	5546	5505	1.0074	1.0106
BT-20	GSK1059615	0.04	uM	LJP6	72	hr	1657	4714	5505	0.8562	0.7943
BT-20	GSK1904529A	0.04	uM	LJP6	72	hr	1657	4830	5505	0.8773	0.8245
BT-20	Omipalisib	0.04	uM	LJP6	72	hr	1657	1613	5505	0.2930	-0.0116
BT-20	GSK 690693	0.04	uM	LJP5	72	hr	1657	4744	5505	0.8617	0.8021
BT-20	GW843682X	0.04	uM	LJP6	72	hr	1657	4886	5505	0.8875	0.8390
BT-20	HG-5-113-01	0.04	uM	LJP5	72	hr	1657	5252	5505	0.9539	0.9341
BT-20	HG-5-88-01	0.04	uM	LJP6	72	hr	1657	4635	5505	0.8420	0.7739
BT-20	Imatinib	0.04	uM	LJP6	72	hr	1657	5484	5505	0.9961	0.9945
BT-20	JNK-9L	0.04	uM	LJP6	72	hr	1657	4504	5505	0.8181	0.7398
BT-20	JW-7-24-1	0.04	uM	LJP6	72	hr	1657	4770	5505	0.8664	0.8089
BT-20	Lapatinib	0.04	uM	LJP6	72	hr	1657	4984	5505	0.9053	0.8645
BT-20	LDN-193189	0.04	uM	LJP5	72	hr	1657	5401	5505	0.9811	0.9730
BT-20	Linifanib	0.04	uM	LJP6	72	hr	1657	5888	5505	1.0694	1.0994
BT-20	Linsitinib	0.04	uM	LJP5	72	hr	1657	4776	5505	0.8676	0.8106
BT-20	Mitoxantrone	0.04	uM	LJP5	72	hr	1657	2816	5505	0.5115	0.3011
BT-20	Mitoxantrone	0.04	uM	LJP6	72	hr	1657	2752	5505	0.4999	0.2845
BT-20	MK2206	0.04	uM	LJP6	72	hr	1657	5368	5505	0.9751	0.9643
BT-20	Neratinib	0.04	uM	LJP5	72	hr	1657	4519	5505	0.8208	0.7436
BT-20	Nilotinib	0.04	uM	LJP5	72	hr	1657	5364	5505	0.9743	0.9632
BT-20	Nintedanib	0.04	uM	LJP6	72	hr	1657	5730	5505	1.0408	1.0584
BT-20	NU7441	0.04	uM	LJP5	72	hr	1657	5736	5505	1.0419	1.0599
BT-20	Dactolisib	0.04	uM	LJP5	72	hr	1657	2762	5505	0.5017	0.2870
BT-20	NVP-TAE684	0.04	uM	LJP6	72	hr	1657	5496	5505	0.9983	0.9976
BT-20	Palbociclib	0.04	uM	LJP6	72	hr	1657	4057	5505	0.7370	0.6237

|<
<<
Previous
Page 3 of 166
Next
>>
>
51 to 75 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)